Inventor · disambiguated record
Ken Phares
Also filed as: PHARES KEN
17 granted patents·6 pending applications·928 citations·filing 2004–2023
97Inventor score
Top patents by PatentIndex Score
23 records- 0199US9050311B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2013·Granted Jun 9, 2015·59 cites·11 claims
- 0298US11292758B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2021·Granted Apr 5, 2022·3 cites·12 claims
- 0398US9624156B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Apr 18, 2017·30 cites·31 claims
- 0498US9422223B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Aug 23, 2016·44 cites·16 claims
- 0598US9278901B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 8, 2016·47 cites·12 claims
- 0698US8536363B2Compounds and methods for delivery of prostacyclin analogsPHARES KEN·Filed 2012·Granted Sep 17, 2013·70 cites·5 claims
- 0798US8410169B2Compounds and methods for delivery of prostacyclin analogsPHARES KEN·Filed 2005·Granted Apr 2, 2013·60 cites·11 claims
- 0898US8252839B2Compounds and methods for delivery of prostacyclin analogsPHARES KEN·Filed 2008·Granted Aug 28, 2012·70 cites·5 claims
- 0998US8232316B2Compounds and methods for delivery of prostacyclin analogsPHARES KEN·Filed 2011·Granted Jul 31, 2012·71 cites·7 claims
- 1098US7544713B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2006·Granted Jun 9, 2009·108 cites·26 claims
- 1198US7417070B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2004·Granted Aug 26, 2008·155 cites·3 claims
- 1298US7384978B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2006·Granted Jun 10, 2008·138 cites·14 claims
- 1397US9878972B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2016·Granted Jan 30, 2018·19 cites·34 claims
- 1497US9199908B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2014·Granted Dec 1, 2015·46 cites·11 claims
- 1595US10947177B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2019·Granted Mar 16, 2021·3 cites·48 claims
- 1684US2022289660A1Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1777US9822057B2Solid forms of treprostinilUNITED THERAPEUTICS CORP·Filed 2014·Granted Nov 21, 2017·5 cites·44 claims
- 1875US2020181057A1Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 1973US2023255922A1Treprostinil prodrugsUNITED THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 2071US2018141891A1Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 2168US11672775B2Treprostinil prodrugsUNITED THERAPEUTICS CORP·Filed 2021·Granted Jun 13, 2023·0 cites·6 claims
- 2259US2018153847A1Treprostinil prodrugsUNITED THERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 2336US2017095432A1Treprostinil formulationsUNITED THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ken Phares files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →